For instance, TRPV2 activation by CBD can sensitize GBM cells to chemotherapeutic agents currently used, e.g., TMZ, carmustine (BCNU) and doxorubicin (DOXO) (Nabissi et al., 2013, 2015). Here, TRPV2 is linked to glioblastoma.